Furthermore, FDA is proposing two other constraints about the submission of a supplemental PMTA. Under proposed § 1114.fifteen(a), a supplemental PMTA could not be submitted exactly where the advertising and marketing get for the initial tobacco item has long been withdrawn or is briefly suspended o